Major associated conditions, significant laboratory data, and treatment in patients with gout receiving allopurinol
| Group A n=52 | Group B n=68 | p Value | |
| Diabetes mellitus (n, %) | 3 (5.7) | 7 (10.2) | NS |
| Hypertension (n, %) | 13 (25) | 20 (29) | NS |
| Hyperlipidaemia (n, %) | 13 (25) | 12 (18) | NS |
| Haemoglobin (g/l)1-150 | 160 (13) | 146 (26) | 0.002 |
| Packed cell volume | 0.49 (0.04) | 0.46 (0.08) | 0.005 |
| Creatinine (μmol/l)1-150 | 100 (18) | 120 (53) | 0.003 |
| BUN (mmol/l)1-150 | 11.5 (4.5) | 16.5 (8.0) | 0.000 |
| CrC (ml/min)1-150 | 103.8 (21.8) [99.7] | 54.6 (20.1) [52.9] | 0.000 |
| Allopurinol maintenance doses (mg/day) | |||
| 100–<300, n (%) | 4 (8) | 1 (2) | NS |
| 300, n (%) | 46 (88) | 62 (91) | NS |
| >300, n (%) | 2 (4) | 5 (7) | NS |
| Other treatments, n (%) | 34 (65) | 49 (72) | NS |
BUN = blood urea nitrogen; CrC = creatinine clearance.
↵1-150 Values represent mean (SD) [median].